Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-01 00:11 | 2024-02-27 | AUPH | Aurinia Pharmaceuticals Inc. | Knappertz Volker | Officer; EVP, Research and Development | Pharmaceutical Preparations | SALE | $6.10 | 4,930 | $30,073 | 319,128 | -1.5% |
| 2024-02-23 00:35 | 2024-02-20 | AUPH | Aurinia Pharmaceuticals Inc. | Knappertz Volker | Officer; EVP, Research and Development | Pharmaceutical Preparations | SALE | $5.48 | 25,146 | $137,800 | 324,058 | -7.2% |
| 2021-03-31 03:00 | 2021-03-26 | GWPH | N/A | Knappertz Volker | Director | Other | SALE | $18.10 | 3,060 | $55,386 | 92,412 | -3.2% |
| 2021-01-21 04:00 | 2021-01-19 | GWPH | N/A | Knappertz Volker | Officer; Chief Medical Officer | Other | SALE | $11.67 | 6,000 | $70,020 | 17,940 | -25.1% |
| 2020-11-26 04:00 | 2020-11-24 | GWPH | N/A | Knappertz Volker | Officer; Chief Medical Officer | Other | SALE | $10.50 | 12,000 | $126,000 | 23,940 | -33.4% |
| 2020-11-14 04:00 | 2020-11-11 | GWPH | N/A | Knappertz Volker | Officer; Chief Medical Officer | Other | SALE | $10.00 | 6,000 | $60,000 | 35,940 | -14.3% |
| 2020-11-06 04:00 | 2020-11-04 | GWPH | N/A | Knappertz Volker | Officer; Chief Medical Officer | Other | SALE | $9.17 | 6,000 | $55,020 | 41,940 | -12.5% |
| 2020-08-07 03:01 | 2020-08-04 | GWPH | N/A | Knappertz Volker | Officer; Chief Medical Officer | Other | SALE | $11.11 | 6,000 | $66,660 | 47,940 | -11.1% |
| 2020-07-23 03:00 | 2020-07-20 | GWPH | N/A | Knappertz Volker | Officer; Chief Medical Officer | Other | SALE | $11.42 | 6,000 | $68,520 | 53,940 | -10.0% |
| 2020-06-20 03:02 | 2019-05-15 | GWPH | N/A | Knappertz Volker | Officer; Chief Medical Officer | Other | SALE | $11.17 | 22,296 | $249,151 | 59,940 | -27.1% |
| 2020-03-05 02:01 | 2020-03-02 | GWPH | N/A | Knappertz Volker | Officer; Chief Medical Officer | Other | SALE | $8.32 | 3,420 | $28,454 | 79,392 | -4.1% |
| 2020-02-29 02:02 | 2020-02-26 | GWPH | N/A | Knappertz Volker | Officer; Chief Medical Officer | Other | SALE | $9.18 | 3,012 | $27,636 | 82,812 | -3.5% |
| 2019-05-22 03:00 | 2019-05-20 | GWPH | N/A | Knappertz Volker | Officer; Chief Medical Officer | Other | OPT+S | $14.64 | 12,144 | $177,845 | 85,824 | -12.4% |
| 2019-03-06 05:06 | 2019-03-01 | GWPH | N/A | Knappertz Volker | Officer; Chief Medical Officer | Other | SALE | $14.46 | 3,732 | $53,965 | 8,736 | -29.9% |
| 2019-03-01 01:05 | 2019-02-26 | GWPH | N/A | Knappertz Volker | Officer; Chief Medical Officer | Other | OPT+S | $12.46 | 4,140 | $51,568 | 12,468 | -24.9% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.